Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
2023.2000
-3.40
(
-0.17
%)
NSE
Jun 12, 2025
15:31 PM
31.12% Gain from 52W Low
Volume:
1.4M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
15 May 2024
US FDA Approval
2023.20
-0.17%
LUPIN LIMITED
Hold:
Lupin Ltd.
by
Geojit BNP Paribas
Target: 1763
Target
Geojit BNP Paribas
Lupin Ltd. has gained
25.35%
in the last 1 Year
More from Lupin Ltd.
Recommended
Market closes lower, SG Mart bags orders worth Rs 266 crore for solar structures
Trendlyne Marketwatch |
12 Jun 2025, 04:08PM
Valuations in some sectors are too hot | Screener: Rising stocks with PE below long term averages
The Baseline |
11 Jun 2025, 10:07PM
Lupin expects normalization by September quarter
|
17 Apr 2020